Gl. Zornberg et Hg. Pope, TREATMENT OF DEPRESSION IN BIPOLAR DISORDER - NEW DIRECTIONS FOR RESEARCH, Journal of clinical psychopharmacology, 13(6), 1993, pp. 397-408
The objective of the study was to review the clinical literature on th
e acute, somatic treatment of the depressed phase of bipolar disorder.
We reviewed all available published studies of ''standard'' somatic t
reatments (lithium, antidepressant and anticonvulsant agents, and elec
troconvulsive therapy [ECT]) reporting three or more depressed bipolar
patients who were not psychotic, rapid cycling, or previously treatme
nt refractory. We also reviewed all studies of ''nonstandard'' pharmac
ologic treatments involving even a single case of a depressed bipolar
patient. Data sources included the MEDLINE database and relevant refer
ences from articles obtained in this search and in major reviews. Five
of seven studies comparing ECT with antidepressant agents find ECT mo
re efficacious. Eight of nine controlled comparisons find lithium supe
rior to placebo in depressed bipolar patients. Three controlled compar
isons of lithium to tricyclic antidepressants suggest that lithium is
equivalent to tricyclic drugs in such patients. Three double-blind, co
ntrolled studies indicate that carbamazepine is more effective than pl
acebo. Limited data on other antidepressant classes suggest that monoa
mine oxidase inhibitors, bupropion, and serotonergic agents may offer
some advantages over tricyclic antidepressants in this population. Som
e ''nonstandard'' treatments also show some potential in bipolar patie
nts. The possibility of switching into a manic episode is an important
consideration with many of the agents studied, although little remain
s known about spontaneous versus treatment-associated mood shifts. In
contrast to the extensive literature on the acute treatment of the man
ic phase of bipolar disorder and on the prophylaxis of manic and depre
ssive episodes, there are few studies of treatment of the depressed ph
ase of bipolar disorder, and their results generally are limited or in
conclusive. Lithium generated a revolution in psychiatric treatment, b
ut the treatment of the depressed phase of bipolar disorder remains a
relatively neglected corner of the field. Several study designs may he
lp to augment knowledge in the treatment of bipolar depression.